IL127620A0 - Method for producing therapeutic DNA - Google Patents

Method for producing therapeutic DNA

Info

Publication number
IL127620A0
IL127620A0 IL12762097A IL12762097A IL127620A0 IL 127620 A0 IL127620 A0 IL 127620A0 IL 12762097 A IL12762097 A IL 12762097A IL 12762097 A IL12762097 A IL 12762097A IL 127620 A0 IL127620 A0 IL 127620A0
Authority
IL
Israel
Prior art keywords
therapeutic dna
producing therapeutic
producing
dna
therapeutic
Prior art date
Application number
IL12762097A
Other languages
English (en)
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of IL127620A0 publication Critical patent/IL127620A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12762097A 1996-07-04 1997-06-24 Method for producing therapeutic DNA IL127620A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9608327A FR2750704B1 (fr) 1996-07-04 1996-07-04 Procede de production d'adn therapeutique
PCT/FR1997/001116 WO1998001540A1 (fr) 1996-07-04 1997-06-24 Procede de production d'adn therapeutique

Publications (1)

Publication Number Publication Date
IL127620A0 true IL127620A0 (en) 1999-10-28

Family

ID=9493705

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12762097A IL127620A0 (en) 1996-07-04 1997-06-24 Method for producing therapeutic DNA

Country Status (14)

Country Link
US (2) US6410273B1 (xx)
EP (1) EP0914418A1 (xx)
JP (1) JP2000514293A (xx)
KR (1) KR20000022488A (xx)
AU (1) AU722909B2 (xx)
BR (1) BR9710173A (xx)
CA (1) CA2258792A1 (xx)
CZ (1) CZ438298A3 (xx)
FR (1) FR2750704B1 (xx)
IL (1) IL127620A0 (xx)
NO (1) NO986177L (xx)
SK (1) SK181498A3 (xx)
WO (1) WO1998001540A1 (xx)
ZA (1) ZA975959B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026468B2 (en) 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US7807822B2 (en) 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
US7026155B2 (en) * 1999-02-02 2006-04-11 Regents Of The University Of California Method of reducing bacterial proliferation
US6667174B2 (en) * 2000-09-18 2003-12-23 Genzyme Corporation Expression vectors containing hybrid ubiquitin promoters
GB0025913D0 (en) * 2000-10-23 2000-12-06 Guldberg Per Materials and methods relating to nucleic acid amplification and profiling
US20030152950A1 (en) * 2001-06-27 2003-08-14 Garner Harold R. Identification of chemically modified polymers
US6989265B2 (en) * 2002-01-23 2006-01-24 Wisconsin Alumni Research Foundation Bacteria with reduced genome
US20060270043A1 (en) * 2002-01-23 2006-11-30 Blattner Frederick R Bacteria with reduced genome
US8765408B2 (en) 2002-01-23 2014-07-01 Wisconsin Alumni Research Foundation Prophage element-free bacteria
US8119365B2 (en) * 2002-01-23 2012-02-21 Wisconsin Alumni Research Foundation Insertion sequence-free bacteria
US8039243B2 (en) * 2002-01-23 2011-10-18 Wisconsin Alumni Research Foundation Insertion sequence-free bacteria
US7303906B2 (en) 2002-09-06 2007-12-04 Wisconsin Alumni Research Foundation Competent bacteria
AU2006247857B2 (en) * 2005-05-11 2009-10-22 Loma Linda University Substances, compositions and methods for preventing and treating immune-mediated inflammatory disorders
US20090191218A1 (en) 2005-05-11 2009-07-30 Fengchun Li DNA Vaccines And Methods For The Prevention Of Transplantation Rejection
WO2008039980A2 (en) * 2006-09-28 2008-04-03 Loma Linda University Apoptotic cell-mediated transfection of mammalian cells with interfering rna
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
US11680273B2 (en) 2011-09-23 2023-06-20 Loma Linda University Treatment of autoimmune diseases
EP2758074B1 (en) 2011-09-23 2020-04-22 Loma Linda University Bacterial strains expressing methylase genes and uses thereof
EP3921416A1 (en) * 2019-02-06 2021-12-15 Fred Hutchinson Cancer Research Center Minicircle producing bacteria engineered to differentially methylate nucleic acid molecules therein

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US5491060A (en) * 1989-05-01 1996-02-13 The University Of Maryland Mutant strain of E. coli for detection of methyltransferase clones
DE69019890T2 (de) * 1989-08-07 1996-02-08 Yissum Res Dev Co Verfahren zur Produktion von der Spiroplasma sp. DNA Methylase.
US5405760A (en) * 1992-04-30 1995-04-11 New England Biolabs, Inc. Process for producing recombinant McrBC endonuclease and cleavage of methylated DNA
US5470740A (en) * 1993-11-04 1995-11-28 Life Technologies, Inc. Cloned NsiI restriction-modification system
US5587305A (en) * 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
FR2714830B1 (fr) 1994-01-10 1996-03-22 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
ATE420171T1 (de) * 1994-07-15 2009-01-15 Univ Iowa Res Found Immunomodulatorische oligonukleotide
FR2730637B1 (fr) 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
FR2739292B1 (fr) 1995-09-28 1997-10-31 Rhone Poulenc Rorer Sa Composition pharmaceutique utile pour la transfection d'acides nucleiques et ses utilisations
FR2741066B1 (fr) 1995-11-14 1997-12-12 Rhone Poulenc Rorer Sa Nouveaux agents de transfection et leurs applications pharmaceutiques
FR2754272B1 (fr) 1996-10-08 1998-11-13 Rhone Poulenc Rorer Sa Procede de preparation de compositions pour le transfert d'acides nucleiques
US6060245A (en) 1996-12-13 2000-05-09 Stratagene Methods and adaptors for generating specific nucleic acid populations

Also Published As

Publication number Publication date
NO986177L (no) 1999-02-15
SK181498A3 (en) 1999-07-12
CZ438298A3 (cs) 1999-04-14
BR9710173A (pt) 1999-08-10
US20020187527A1 (en) 2002-12-12
CA2258792A1 (fr) 1998-01-15
AU722909B2 (en) 2000-08-17
US6410273B1 (en) 2002-06-25
FR2750704B1 (fr) 1998-09-25
NO986177D0 (no) 1998-12-29
FR2750704A1 (fr) 1998-01-09
AU3447597A (en) 1998-02-02
EP0914418A1 (fr) 1999-05-12
KR20000022488A (ko) 2000-04-25
WO1998001540A1 (fr) 1998-01-15
ZA975959B (en) 1998-01-30
JP2000514293A (ja) 2000-10-31

Similar Documents

Publication Publication Date Title
HU9700851D0 (en) Method for producing l-lysin
IL127620A0 (en) Method for producing therapeutic DNA
HUP9603179A3 (en) Process for producing benzyl-ethers
EP0946180A4 (en) METHODS FOR STIMULATING BONE FORMATION
HU9700140D0 (en) Process for producing 0-demethyl-tramadol-enantiomeres
HUP9700380A2 (en) Process for producing 4-oxoimidazolinium-salts
GB9410320D0 (en) Novel therapeutic method
GB9719161D0 (en) New therapeutic method
HU9700212D0 (en) Process for producing alkyl-chlorides
HUP0003203A3 (en) Process for producing bisindolymalimides
GB9515868D0 (en) Therapeutic method
HUP0001596A3 (en) Method for producing 5-aminomethyl-2-chloropyridines
HU9802054D0 (en) Process for producing pentafluorpentanol
HUP0003768A3 (en) Method for producing thiochloroformates
IL130092A0 (en) Method for producing 2-chloro-5-aminomethylthiazole from 2-chloro-5-methylthiazole via 2-chloro-5-chloromethylthiazole
HUP9802955A3 (en) Process for producing amino-cyano-acetamide
EP0990658A4 (en) PROCESS FOR PRODUCING TRIHYDROCARBYLALUMINUMS
HUP0100505A3 (en) Method for producing chlorobenzoxazolene
IL132968A0 (en) Method for producing 2-cyclododecyl-1-propanol
HK1018239A1 (en) Method for producing bound volumes
HU9701137D0 (en) Process for producing pharmaceutical intermedier
HUP9902747A3 (en) Method for producing therapeutic dna
HUP9801800A3 (en) Process for producing 1-pyruvoyl-l-proline
GB9719189D0 (en) New therapeutic method
GB9719176D0 (en) New therapeutic method